The study aims to test the immunogenicity, efficacy, and safety of OVX836 in shielding individuals from influenza infections.

Under the agreement, the two parties will collaborate on research and development, production, clinical trials of new drugs ...

The global research antibodies and reagents market is projected to grow at a CAGR of 7% from 2025 to 2030, driven by ...

On 03 September 2025, Hoffmann-La Roche conducted a study is to assess the long-term safety and to explore the efficacy of ...

Alteogen Inc. (KOSDAQ:196170) announced today that the European Commission (EC) has granted marketing authorization for EYLUXVI® (code name: ALT-L9), an Eylea® biosimilar co-developed by its ...

For decades, cancer has been spoken of in hushed tones across the world, a death sentence for millions, especially in regions ...

Flu vaccines are now available nationwide. Here's what you need to know about eligibility, timing, and cost of the vaccine ...

The Indian scientific community has achieved a historic milestone by creating AdFalciVax as the nation's first homegrown ...

LONDON, GREATER LONDON, UNITED KINGDOM, September 11, 2025 /EINPresswire / -- How Big Is The Human Serum Albumin Market In 2025?

DENVER, Sept. 12, 2025 (GLOBE NEWSWIRE) -- 247marketnews.com, a pioneer in digital media dedicated to the swift distribution of financial ...